Gilead Sciences Crecimiento futuro
Future controles de criterios 2/6
Gilead Sciences se prevé un crecimiento anual de los beneficios y los ingresos de 7.2% y 2.2% respectivamente. Se prevé que el BPA sea de grow en 8.5% al año. Se prevé que la rentabilidad de los fondos propios sea de 26.2% en 3 años.
Información clave
10.0%
Tasa de crecimiento de los beneficios
10.2%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Biotechs | 20.7% |
Tasa de crecimiento de los ingresos | 2.2% |
Rentabilidad financiera futura | 32.9% |
Cobertura de analistas | Good |
Última actualización | 17 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Gilead Sciences: Realizing Financial Projections Is Key
Mar 20Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77
Mar 13Gilead's Business Development: The Good, The Bad, And The Spinning Kite Solution
Mar 01Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77
Feb 28We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated
Feb 15Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77
Feb 13Gilead Sciences: Cheap For A Reason
Feb 10Gilead Sciences: The Sky Is Not Falling
Feb 01Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?
Jan 15What Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is Not Telling You
Dec 25These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well
Nov 17Does Gilead Sciences (NASDAQ:GILD) Deserve A Spot On Your Watchlist?
Oct 10We Think Gilead Sciences (NASDAQ:GILD) Can Stay On Top Of Its Debt
Aug 11Here's Why Gilead Sciences (NASDAQ:GILD) Has Caught The Eye Of Investors
Jul 04Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 28,680 | 7,310 | 9,827 | 10,132 | 22 |
12/31/2025 | 27,956 | 6,844 | 9,362 | 9,603 | 27 |
12/31/2024 | 27,511 | 2,732 | 8,875 | 9,434 | 27 |
12/31/2023 | 27,116 | 5,665 | 7,421 | 8,006 | N/A |
9/30/2023 | 27,391 | 5,876 | 7,853 | 8,404 | N/A |
6/30/2023 | 27,382 | 5,484 | 8,926 | 9,512 | N/A |
3/31/2023 | 27,043 | 5,583 | 8,386 | 8,976 | N/A |
12/31/2022 | 27,281 | 4,592 | 8,344 | 9,072 | N/A |
9/30/2022 | 27,136 | 3,334 | 9,007 | 9,710 | N/A |
6/30/2022 | 27,515 | 4,137 | 9,415 | 10,100 | N/A |
3/31/2022 | 27,472 | 4,515 | 9,953 | 10,614 | N/A |
12/31/2021 | 27,305 | 6,225 | 10,805 | 11,384 | N/A |
9/30/2021 | 27,482 | 7,394 | 9,491 | 10,095 | N/A |
6/30/2021 | 26,638 | 5,162 | 8,472 | 9,092 | N/A |
3/31/2021 | 25,564 | 301 | 8,698 | 9,342 | N/A |
12/31/2020 | 24,689 | 123 | 7,518 | 8,168 | N/A |
9/30/2020 | 23,147 | 1,268 | 8,160 | 8,832 | N/A |
6/30/2020 | 22,174 | -257 | 8,510 | 9,227 | N/A |
3/31/2020 | 22,716 | 4,962 | 8,244 | 9,003 | N/A |
12/31/2019 | 22,449 | 5,386 | 8,319 | 9,144 | N/A |
9/30/2019 | 22,365 | 2,693 | 8,039 | 8,909 | N/A |
6/30/2019 | 22,357 | 5,955 | 7,639 | 8,476 | N/A |
3/31/2019 | 22,320 | 5,892 | 6,758 | 7,707 | N/A |
12/31/2018 | 22,127 | 5,455 | 7,476 | 8,400 | N/A |
9/30/2018 | 22,281 | 1,587 | 7,912 | 8,808 | N/A |
6/30/2018 | 23,197 | 2,208 | 8,432 | 9,290 | N/A |
3/31/2018 | 24,690 | 3,464 | 10,559 | 11,243 | N/A |
12/31/2017 | 26,107 | 4,628 | 11,308 | 11,898 | N/A |
9/30/2017 | 27,478 | 11,601 | N/A | 12,684 | N/A |
6/30/2017 | 28,466 | 12,213 | N/A | 14,383 | N/A |
3/31/2017 | 29,101 | 12,637 | N/A | 15,842 | N/A |
12/31/2016 | 30,390 | 13,501 | N/A | 17,047 | N/A |
9/30/2016 | 31,576 | 15,076 | N/A | 18,382 | N/A |
6/30/2016 | 32,371 | 16,346 | N/A | 18,085 | N/A |
3/31/2016 | 32,839 | 17,341 | N/A | 18,758 | N/A |
12/31/2015 | 32,639 | 18,108 | N/A | 21,250 | N/A |
9/30/2015 | 31,447 | 16,912 | N/A | 18,476 | N/A |
6/30/2015 | 29,194 | 15,043 | N/A | 18,424 | N/A |
3/31/2015 | 27,485 | 14,207 | N/A | 16,951 | N/A |
12/31/2014 | 24,890 | 12,101 | N/A | 12,818 | N/A |
9/30/2014 | 20,696 | 9,406 | N/A | 10,524 | N/A |
6/30/2014 | 17,437 | 7,463 | N/A | 7,233 | N/A |
3/31/2014 | 13,669 | 4,580 | N/A | 4,001 | N/A |
12/31/2013 | 11,202 | 3,075 | N/A | 3,105 | N/A |
9/30/2013 | 10,585 | 3,046 | N/A | 3,084 | N/A |
6/30/2013 | 10,229 | 2,933 | N/A | 3,076 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: GILD(7.2% al año) es superior a la tasa de ahorro (2.2%).
Beneficios vs. Mercado: GILDSe prevé que los beneficios de la empresa (7.2% al año) crezcan menos que el mercado US (14.9% al año).
Beneficios de alto crecimiento: GILDSe prevé que los beneficios de la empresa crezcan, pero no significativamente.
Ingresos vs. Mercado: GILD(2.2% al año) se prevé que crezca más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: GILDSe prevé que los ingresos de la empresa (2.2% al año) crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: GILDse prevé que la Rentabilidad de los fondos propios sea alta dentro de 3 años (26.2%)